Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rang in Aktien #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aktienkurs
$0.16240909
Zuletzt synchronisiert: 2025-03-04
Marktkapitalisierung
$35.68M
Veränderung (1 Tag)
0.27%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategorie

Aktien-Split-Historie für Dali Pharmaceuticalco.,Ltd (603963)
Die Aktie Dali Pharmaceuticalco.,Ltd (Symbol: 603963) durchlief insgesamt 3 Aktiensplits.
Der letzte Aktiensplit fand am Jun 08, 2020 statt.
Eine 603963-Aktie, die vor dem Jul 05, 2018 gekauft wurde, entspricht heute 2.197 603963-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2020-06-08 13:10 x1.3 x2.197
2019-06-10 13:10 x1.3 x1.69
2018-07-05 13:10 x1.3 x1.3
Aktiensplits ähnlicher Unternehmen oder Wettbewerber